Abstract
The existing guidelines regarding the management of invasive pulmonary aspergillosis do not recommend screening of the extra-pulmonary sites. Due to the fact that the presence of central nervous system (CNS) aspergillosis will influence treatment decisions regarding which antifungal to use and the aimed target concentrations of azoles in plasma, to be informed about dissemination of the infection to the CNS is absolutely necessary. We demonstrate the need for a structured approach to screening of pediatric patients for CNS aspergillosis.
| Original language | English |
|---|---|
| Pages (from-to) | 8-11 |
| Number of pages | 4 |
| Journal | Medical Mycology Case Reports |
| Volume | 4 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Apr 2014 |
| Externally published | Yes |
Keywords
- Aspergillosis
- Central nervous system
- Pediatrics
- Screening
- Therapeutic drug monitoring
- Voriconazole
Fingerprint
Dive into the research topics of 'Screening of the central nervous system in children with invasive pulmonary aspergillosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver